Berberis crataegina DC.
Novel Drug Targets with Traditional Herbal Medicines: Scientific and Clinical Evidence, Springer International Publishing Ag, ss.37-47, 2022
- Yayın Türü: Kitapta Bölüm / Araştırma Kitabı
- Basım Tarihi: 2022
- Doi Numarası: 10.1007/978-3-031-07753-1_3
- Yayınevi: Springer International Publishing Ag
- Sayfa Sayıları: ss.37-47
- Anahtar Kelimeler: Alkaloid, Berberine, Berberis crataegina, Ethnobotany, Medicinal and therapeutic values
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Berberidaceae, which grows in the northern hemisphere’s temperate regions, is a family of perennial herbaceous plants and shrubs. Some members of the Berberis species only grow naturally in certain areas. Berberis crataegina DC., one of these species, is used locally in Turkey, Iran, and Turkmenistan as a food and in the treatment of various diseases. While the fruits of B. crataegina are used as food, diuretic, and expectorant, its root, bark, and branches have an ethnobotanical uses such as antipyretic, anthelmintic, anti-inflammatory, and antidiabetic. Especially in Turkish folk medicine, it has been used against jaundice, hemorrhoids, and dysuria and as fever reducer, tonic, and appetizer in fever cases. Considering all this information, it is thought that B. crataegina should be evaluated in terms of phytotherapeutic, pharmacological, and toxicologic potential. Therefore, it is compiled to studies on B. crataegina extracts in the literature, and one of the major components of B. crataegina, berberine, was also examined. Hence, this study analyzes and presents the current research in the therapeutic use, content analysis, in vivo and/or pharmacological and toxicological studies of B. crataegina and offers suggestions for future reference.